Consejo Asesor Científico

Alexander Knuth, MD

Hamad Medical Corporation

Doha, Qatar

Dr. Alexander Knuth is the medical director and chief executive officer of the National Center for Cancer Care and Research at Hamad Medical Corporation.

Dr. Knuth’s pioneering work in cancer immunology led to the discovery of multiple human cancer antigens including MAGE, the first of the so-called cancer/testis (CT) antigens that have been a primary target of vaccine strategies to date. He also played a pivotal role in the development of peptide-based vaccines and adjuvants, established immune-monitoring techniques, and discovered tumor escape mechanisms. He has received many awards, including the prestigious Johann-Georg-Zimmermann Medal.

In addition to being a member of CRI’s Scientific Advisory Council, Dr. Knuth serves on the CLIP Grant Review Committee and is a member of CRI’s global clinical investigator network.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.